The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

Investors in Hologic, Inc. HOLX need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $40.00 Call had some of the highest implied ...

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, ...

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Minicarm.com: Your Go-To Source for Hologic Fluoroscan Mini C-Arm Sales, Parts & Service HAUPPAUGE, NEW YORK / ACCESS Newswire / February 4, 2025 / Hologic has officially announced the End-of-Sale and ...

Shares of Hologic Inc. HOLX slipped 1.46% to $63.53 Wednesday, on what proved to be an all-around rough trading session for ...

Reports Q1 revenue $1.02B, consensus $1.02B. “Our financial results for the first quarter of 2025 were consistent with our guidance overall,” ...

Hologic HOLX is set to release first-quarter fiscal 2025 results on Feb. 5 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus ...

(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...